• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·VNDA
Held by 2 Gurus
Share

Vanda Pharmaceuticals Inc. Stocks

$ 5.44Last Updated 25.08.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 325.93M

In Guru Portfolios

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Steven CohenPoint72 Asset Management, L.P.0.0%+0.00%
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%

Trending

27.08.2026 03:12

Nvidia's forecast for next year sent its stock soaring after the earnings report. What did the company promise?

27.08.2026 01:36

Nvidia's revenue more than doubled in the second quarter. Why aren't investors impressed?

27.08.2026 00:57

Alibaba has released Qwen, an affordable AI model, for free use

27.08.2026 00:42

An investor from "Betting on a Downturn" hedged against a rise in Nvidia's stock price

26.08.2026 23:49

Samsung Will Pay Swatch Nearly $12 Million Over Digital Copies of Watches in Its App Store

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026